Amale Hawi

1.4k total citations
26 papers, 1.0k citations indexed

About

Amale Hawi is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Amale Hawi has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Pharmaceutical Science. Recurrent topics in Amale Hawi's work include Synthesis and Biological Evaluation (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Amale Hawi is often cited by papers focused on Synthesis and Biological Evaluation (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Amale Hawi collaborates with scholars based in United States, United Kingdom and Brazil. Amale Hawi's co-authors include Mehran Yazdanian, Thomas Sciascia, G. W. H. Cheeseman, George A. Digenis, M L Thomas, Jennifer Fiegel, Willem Andreas Germishuizen, Lucila Garcia‐Contreras, M Telko and David A. Edwards and has published in prestigious journals such as Analytical Biochemistry, Antimicrobial Agents and Chemotherapy and Life Sciences.

In The Last Decade

Amale Hawi

23 papers receiving 969 citations

Peers

Amale Hawi
Kimberley A. Lentz United States
Lori H. Takahashi United States
Elke Lipka United States
Anders Buur Denmark
Richard Lloyd United Kingdom
Richard A. Morrison United States
Viera Lukáčová United States
Sang M. Chung United States
Barbra H. Stewart United States
Gordon Beck United Kingdom
Kimberley A. Lentz United States
Amale Hawi
Citations per year, relative to Amale Hawi Amale Hawi (= 1×) peers Kimberley A. Lentz

Countries citing papers authored by Amale Hawi

Since Specialization
Citations

This map shows the geographic impact of Amale Hawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amale Hawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amale Hawi more than expected).

Fields of papers citing papers by Amale Hawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amale Hawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amale Hawi. The network helps show where Amale Hawi may publish in the future.

Co-authorship network of co-authors of Amale Hawi

This figure shows the co-authorship network connecting the top 25 collaborators of Amale Hawi. A scholar is included among the top collaborators of Amale Hawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amale Hawi. Amale Hawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birring, Surinder S., Peter V. Dicpinigaitis, Toby M. Maher, et al.. (2025). Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment. Lung. 203(1). 62–62. 1 indexed citations
2.
3.
Riggs, Matthew M., et al.. (2023). A population pharmacokinetic–pharmacodynamic model evaluating efficacy of nalbuphine extended‐release in patients with prurigo nodularis. British Journal of Clinical Pharmacology. 89(7). 2088–2101. 1 indexed citations
4.
5.
Lynch, David R., Steven M. Willi, Robert B. Wilson, et al.. (2012). A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial. Movement Disorders. 27(8). 1026–1033. 66 indexed citations
6.
Hawi, Amale, Sarah L. Heald, & Thomas Sciascia. (2011). Use of an Adaptive Study Design in Single Ascending‐Dose Pharmacokinetics of A0001 (α‐Tocopherylquinone) in Healthy Male Subjects. The Journal of Clinical Pharmacology. 52(1). 65–77. 9 indexed citations
7.
Garcia‐Contreras, Lucila, Jennifer Fiegel, M Telko, et al.. (2007). Inhaled Large Porous Particles of Capreomycin for Treatment of Tuberculosis in a Guinea Pig Model. Antimicrobial Agents and Chemotherapy. 51(8). 2830–2836. 105 indexed citations
8.
Hickey, Anthony J., et al.. (2005). Pharmacokinetics of aerosolized rifampicin large porous particles in the guinea pig. 3 indexed citations
9.
Yazdanian, Mehran, et al.. (2004). The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs. Pharmaceutical Research. 21(2). 293–299. 237 indexed citations
10.
Lamson, Michael, John P. Sabo, Thomas R. MacGregor, et al.. (1999). Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharmaceutics & Drug Disposition. 20(6). 285–291. 53 indexed citations
11.
Yazdanian, Mehran, et al.. (1998). Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds. Pharmaceutical Research. 15(9). 1490–1494. 379 indexed citations
12.
Wells, David A., Amale Hawi, & George A. Digenis. (1992). Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat.. Drug Metabolism and Disposition. 20(1). 124–126. 15 indexed citations
13.
Hawi, Amale, et al.. (1991). Solubilization and in Vitro Spermicidal Assessment of Nonoxynol-9 and Selected Fractions Using Rabbit Spermatozoa. Pharmaceutical Research. 8(3). 403–408. 14 indexed citations
14.
Hawi, Amale, et al.. (1988). Development of an HPLC assay for the analysis of tetrafluoroputrescine—A putrescine analog. Analytical Biochemistry. 172(1). 235–240.
15.
Digenis, George A., et al.. (1986). Detection of tetrafluoroputrescine in RBCS by fluorine-19 nuclear magnetic resonance spectroscopy. Life Sciences. 38(25). 2307–2309. 7 indexed citations
16.
Cheeseman, G. W. H. & Amale Hawi. (1984). ChemInform Abstract: SYNTHESIS OF SOME PYRROLOBENZOTHIAZEPINES VIA N‐ARYL‐2‐THIOCYANATOPYRROLES. Chemischer Informationsdienst. 15(2). 4 indexed citations
17.
Cheeseman, G. W. H. & Amale Hawi. (1983). Synthesis of some pyrrolobenzothiazepines via N‐aryl‐2‐thiocyanatopyrroles. Journal of Heterocyclic Chemistry. 20(3). 585–590. 10 indexed citations
18.
Cheeseman, G. W. H. & Amale Hawi. (1983). Novel rearrangements of N‐arylpyrrolyl sulphides. Journal of Heterocyclic Chemistry. 20(3). 591–593. 6 indexed citations
19.
Hawi, Amale, et al.. (1980). ChemInform Abstract: PHOTOLYSIS OF SOME QUINOXALIN‐2‐ONE 4‐OXIDES. Chemischer Informationsdienst. 11(41). 1 indexed citations
20.
Haddadin, Makhluf J., et al.. (1978). Photolysis of some 1-hydroxybenzimidazole-3-oxides. Tetrahedron Letters. 19(46). 4581–4582. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberley A. Lentz Breakdown of academic impact, for papers by Lori H. Takahashi Breakdown of academic impact, for papers by Elke Lipka Breakdown of academic impact, for papers by Anders Buur Breakdown of academic impact, for papers by Richard Lloyd Breakdown of academic impact, for papers by Richard A. Morrison Breakdown of academic impact, for papers by Viera Lukáčová Breakdown of academic impact, for papers by Sang M. Chung Breakdown of academic impact, for papers by Barbra H. Stewart Breakdown of academic impact, for papers by Gordon Beck
Rankless by CCL
2026